Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-5.053M
Cash
69.35M
Avg Qtr Burn
-42.62M
Short % of Float
17.22%
Insider Ownership
18.09%
Institutional Own.
71.25%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Phase 3 Update | ||
Adintrevimab (ADG20) Details COVID-19 | Phase 3 Update | |
VYD2311 Details COVID-19 | Phase 1 Data readout |